AP News

News Summary: Sanofi profit slumps in 3rd quarter

SHRINKING PROFIT: Sanofi saw its earnings slump in the third quarter as generic competitors ate into profits of its Eloxatin cancer treatment.

DETAILS: Sanofi earned €1.6 billion ($2.1 billion) for the July-September quarter, down 20 percent from €2 billion a year earlier. Sanofi lost €448 million in sales from generic competition in the quarter, although overall sales rose 3.3 percent to €9 billion.

LOOKING AHEAD: The French drugmaker now expects its core earnings to fall 12 percent this year compared to 2011, at constant exchange rates.

Burger King's Young Buns

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus